Stock Analiz

Pediatrix Medical Group, Inc. (MD) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Pediatrix Medical Group’s revenue went from $3.2B in fiscal 2016 to $1.9B in fiscal 2025, a decline of about 5.5% a year.

Net income in fiscal 2025 was $165M, a net margin of 8.6%; the best year in this period was 2016 with $325M.

Over the twelve months to September 30, 2026, revenue was $2.0B and net income $150M.

Free cash flow was $253M in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count fell 8% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2016: $3.2B162017: $3.5B172018: $1.7B182019: $1.8B192020: $1.7B202021: $1.9B212022: $2.0B222023: $2.0B232024: $2.0B242025: $1.9B25$1.9B
Net income
2016: $325M162017: $320M172018: $269M182019: -$1.5B192020: -$796M202021: $131M212022: $66M222023: -$60M232024: -$99M242025: $165M25$165M
Free cash flow
2016: $405M162017: $485M172018: $297M182019: $338M192020: $176M202021: $44M212022: $137M222023: $104M232024: $185M242025: $253M25$253M
EPS (diluted)
2016: $3.49162017: $3.45172018: $2.93182019: $-17.83192020: $-9.55202021: $1.53212022: $0.79222023: $-0.73232024: $-1.19242025: $1.9425$1.94

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$2.0B$1.9B$2.0B$2.0B$2.0B$1.9B$1.7B$1.8B$1.7B$3.5B$3.2B
Gross profit———————————
Operating income$213M$209M-$69M$7M$173M$203M$98M$172M$248M$455M$572M
Net income$150M$165M-$99M-$60M$66M$131M-$796M-$1.5B$269M$320M$325M
EPS (diluted)$1.84$1.94$-1.19$-0.73$0.79$1.53$-9.55$-17.83$2.93$3.45$3.49
R&D———————————
Revenue growth—−4.9%+0.9%+1.1%+3.2%+10.2%−2.6%+3.3%−50.2%+8.6%+14.5%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$227M$271M$207M$137M$167M$77M$205M$358M$314M$511M$444M
Capital spending-$17M-$18M-$22M-$33M-$30M-$32M-$29M-$19M-$17M-$26M-$39M
Free cash flow$210M$253M$185M$104M$137M$44M$176M$338M$297M$485M$405M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks$211M$87M$2M$919000$89M$5M$8M$145M$302M$70M$62M
Stock-based pay$21M$18M$12M$12M$16M$19M$39M$33M$37M$29M$34M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$500M$349M$178M$103M$487M$1.2B$108M$63M$51M$67M
Debt—$635M$662M$702M$713M$1.1B$1.8B$1.8B$2.0B$1.8B$1.7B
Equity—$866M$765M$849M$892M$896M$747M$1.5B$3.1B$3.1B$2.8B
Total assets—$2.2B$2.2B$2.2B$2.3B$2.7B$3.3B$4.1B$5.9B$5.9B$5.3B
Shares (diluted)80M85M83M82M84M86M83M84M92M93M93M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin———————————
Operating margin10.9%10.9%-3.4%0.4%8.8%10.6%5.7%9.7%14.4%13.2%18.0%
Net margin7.7%8.6%-4.9%-3.0%3.4%6.9%-45.9%-84.2%15.6%9.3%10.2%
FCF margin10.7%13.2%9.2%5.2%7.0%2.3%10.1%19.0%17.2%14.0%12.7%
ROIC—10.6%-4.7%0.4%8.3%8.3%3.1%3.8%3.6%7.3%8.1%
ROE—19.1%-13.0%-7.1%7.4%14.6%-106.6%-99.9%8.7%10.4%11.8%

Frequently asked questions

What is Pediatrix Medical Group’s annual revenue?

$1.9B in fiscal 2025 and $2.0B over the twelve months to September 30, 2026.

How much profit does Pediatrix Medical Group make?

Net income was $165M in fiscal 2025 (net margin 8.6%).

Is Pediatrix Medical Group’s revenue growing?

No: revenue fell 4.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.